(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(-0.22%) $82.51
(1.99%) $1.746
(0.25%) $2 394.40
(-0.28%) $28.32
(-0.54%) $949.00
(0.29%) $0.939
(0.50%) $11.05
(0.13%) $0.804
(0.10%) $94.15
Live Chart Being Loaded With Signals
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others...
Stats | |
---|---|
Today's Volume | 783 846 |
Average Volume | 2.72M |
Market Cap | 878.58M |
EPS | $0 ( 2024-02-26 ) |
Last Dividend | $0.0600 ( 2022-09-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.730 |
ATR14 | $0.00500 (0.41%) |
Volume Correlation
Healius Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Healius Ltd Correlation - Currency/Commodity
Healius Ltd Financials
Annual | 2022 |
Revenue: | $1.71B |
Gross Profit: | $341.70M (20.02 %) |
EPS: | $-0.610 |
Q2 | 2023 |
Revenue: | $849.00M |
Gross Profit: | $143.90M (16.95 %) |
EPS: | $-1.070 |
Q4 | 2022 |
Revenue: | $842.80M |
Gross Profit: | $169.50M (20.11 %) |
EPS: | $-0.560 |
Q3 | 2022 |
Revenue: | $421.40M |
Gross Profit: | $144.90M (34.39 %) |
EPS: | $62.56 |
Financial Reports:
No articles found.
Healius Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0600 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0237 | 1999-04-12 |
Last Dividend | $0.0600 | 2022-09-07 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 47 | -- |
Total Paid Out | $3.43 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.43 | -- |
Div. Sustainability Score | 1.719 | |
Div.Growth Potential Score | 1.361 | |
Div. Directional Score | 1.540 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LLC.AX | Ex Dividend Junior | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
STO.AX | Ex Dividend Knight | 2023-08-28 | Semi-Annually | 0 | 0.00% | |
CQE.AX | Ex Dividend Knight | 2023-09-28 | Quarterly | 0 | 0.00% | |
NAC.AX | Ex Dividend Knight | 2023-09-06 | Quarterly | 0 | 0.00% | |
WGB.AX | Ex Dividend Junior | 2023-10-12 | Semi-Annually | 0 | 0.00% | |
EVN.AX | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
PFP.AX | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
ANN.AX | Ex Dividend Knight | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
HPI.AX | Ex Dividend Knight | 2023-06-29 | Semi-Annually | 0 | 0.00% | |
RIC.AX | Ex Dividend Knight | 2023-10-04 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.580 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.325 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.768 | 1.500 | -9.64 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.527 | 0.800 | -2.36 | -1.890 | [1 - 3] |
quickRatioTTM | 0.471 | 0.800 | -1.934 | -1.547 | [0.8 - 2.5] |
cashRatioTTM | 0.144 | 1.500 | -0.313 | -0.470 | [0.2 - 2] |
debtRatioTTM | 0.224 | -1.500 | 6.27 | -9.40 | [0 - 0.6] |
interestCoverageTTM | 1.020 | 1.000 | -0.733 | -0.733 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.443 | 2.00 | 9.85 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.325 | 2.00 | 9.84 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.644 | -1.500 | 7.43 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.185 | 1.000 | -0.246 | -0.246 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0421 | 1.000 | -1.158 | -1.158 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.376 | 1.000 | 9.02 | 9.02 | [0.2 - 2] |
assetTurnoverTTM | 0.561 | 0.800 | 9.59 | 7.68 | [0.5 - 2] |
Total Score | 1.719 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.720 | 1.000 | -0.174 | 0 | [1 - 100] |
returnOnEquityTTM | -0.768 | 2.50 | -6.20 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.325 | 2.00 | 9.89 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.443 | 2.00 | 9.85 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00349 | 1.500 | -3.31 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.150 | 1.000 | 8.75 | 0 | [0.1 - 0.5] |
Total Score | 1.361 |
Healius Ltd
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators